Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:43 PM
Ignite Modification Date:
2025-12-26 @ 10:43 PM
NCT ID:
NCT02842112
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* With a newly diagnosed de novo or secondary type AML (post myelodysplastic syndrome (MDS) or therapy-related AML)
* Patients achieving first CR after induction or salvage therapy
Exclusion Criteria:
* Patients with acute promyelocytic leukemia (APL)
* Concomitant uncontrolled infection, organ dysfunction or medical disease
* left ventricular ejection fraction (LVEF) \< 45% as assessed by echocardiography
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
25 Years
Maximum Age:
72 Years
Study:
NCT02842112
Study Brief:
Protocol Section:
NCT02842112